As the Vice President of Digital Delivery at Maximus, David Kravitz plays a pivotal role in steering the company’s strategic initiatives within the pharmaceutical sector. With over 20 years of experience, David has honed his expertise in managing complex systems and product portfolios, ensuring that...
As the Vice President of Digital Delivery at Maximus, David Kravitz plays a pivotal role in steering the company’s strategic initiatives within the pharmaceutical sector. With over 20 years of experience, David has honed his expertise in managing complex systems and product portfolios, ensuring that digital solutions align seamlessly with business objectives. His current focus is on overseeing a talented team of digital delivery leads, driving the successful implementation of innovative projects that enhance operational efficiency and client satisfaction.
David is deeply committed to the continuous improvement of Maximus's Digital Solutions Methodology, leveraging his extensive background in software development and project lifecycle management. His technical acumen encompasses programming, system design, and software lifecycle management, which enables him to guide his team through the intricacies of the Software Development Life Cycle (SDLC). By fostering a culture of collaboration and excellence, David ensures that resource allocation and team performance are optimized, ultimately delivering high-quality solutions that meet the evolving needs of the pharmaceutical industry.
In addition to his technical and operational expertise, David excels in business case development and strategic planning, providing a solid foundation for the program management office (PMO) he has established. His leadership style emphasizes empowerment and accountability, allowing his team to thrive while navigating the complexities of digital transformation. As a forward-thinking leader, David Kravitz is dedicated to driving innovation and excellence at Maximus, positioning the company as a trusted partner in the digital landscape of the pharmaceutical sector.
